Scandusan SRL
Scandusan reported total assets of 148,461 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026).
The score of Scandusan shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Scandusan's annual accounts
| 2025 | |
|---|---|
| Net result | 129,402 € |
| Equity | 129,569 € |
| Cash | 119,663 € |
| EBITDA | 167,685 € |
| Total assets | 148,461 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
Scandusan's financial analysis
- Solvency87.3%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Scandusan
Scandusan's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1018.960.452
- VAT number
- BE1018960452
- Peppol
- Registered · 0208:1018960452 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jan 2025
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Scandusan (SRL) has been based in Ixelles since 2025, active in: medical specialists activities. For 2025, it reports a net profit of 129,402 € and equity of 129,569 €; its revenue is not published. Its solvency stands at 87.3%, above the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Scandusan
Companies in the same business, of comparable size and area, outside its group.
- Gynemat Medical specialists activities Ixelles · balance sheet 148,811 €
- Dr. Maarten Rombauts Medical specialists activities Lier · balance sheet 146,643 €
- DR Cyril Constant Medecin Anesthesiste Medical specialists activities Ath · balance sheet 148,435 €
- Neurologie Dr. J. Abramski Medical specialists activities Genk · balance sheet 148,549 €
- Dokter Hans Baeten Medical specialists activities Brasschaat · balance sheet 148,556 €
- Alpha Omega Geria Srl Medical specialists activities Lasne · balance sheet 148,360 €
- Endocrino Diabetologie Medical specialists activities Evere · balance sheet 148,241 €
- Zmack-Face Medical specialists activities Antwerp · balance sheet 148,724 €
Frequently asked questions about Scandusan
What is the revenue of Scandusan?
Scandusan files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Scandusan?
In Belgium, the VAT number is the company number prefixed with BE: BE1018960452 for Scandusan, if the company is VAT-registered. Its company number (CBE) is 1018.960.452.
Where is the registered office of Scandusan?
According to the CBE register, the registered office of Scandusan is in 1050 Ixelles.
What is the equity of Scandusan?
At the close of the 2025 financial year, the equity of Scandusan amounts to 129,569 €, a solvency of 87.3% of total assets.
Who manages Scandusan?
The register lists 1 active mandates at Scandusan. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Scandusan
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →